Synthesis and in vitro cytotoxic activity on human anaplastic thyroid cancer cells of lipoamino acid conjugates of gemcitabine

Lipophilic derivatives of the antitumor drug gemcitabine (GEM) with the potential for improving drug loading in lipid‐based colloidal carriers, like liposomes or lipid nanoparticles, are described. GEM free base was conjugated to lipoamino acids bearing an alkyl side chain of different length, by ei...

Full description

Saved in:
Bibliographic Details
Published in:Drug development research 2010-08, Vol.71 (5), p.294-302
Main Authors: Pignatello, Rosario, Vicari, Luisa, Pistarà, Venerando, Musumeci, Teresa, Gulisano, Massimo, Puglisi, Giovanni
Format: Article
Language:English
Subjects:
8305C cells
anaplastic thyroid carcinoma
Aro cells
HPLC determination
lipophilicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lipophilic derivatives of the antitumor drug gemcitabine (GEM) with the potential for improving drug loading in lipid‐based colloidal carriers, like liposomes or lipid nanoparticles, are described. GEM free base was conjugated to lipoamino acids bearing an alkyl side chain of different length, by either a carbodiimide‐assisted or an ethylchloroformiate‐assisted coupling reaction, to obtain N4‐acyl GEM derivatives. These compounds retained the same in vitro cell growth inhibitory activity of the parent drug against two lines of human anaplastic thyroid cancer cells. Stability studies suggested that the observed activity was due mainly to intact derivatives and not to released GEM. Accordingly, these amphiphilic derivatives can be proposed in a further step for the encapsulation in liposomes or lipid nanocarriers, to achieve as a final goal an improvement of the pharmacokinetics and therapeutic activity of GEM. Drug Dev Res 2010. © 2010 Wiley‐Liss, Inc.
ISSN:0272-4391
1098-2299
DOI:10.1002/ddr.20374